Cited by 75Neuropeptides and Animal PhysiologyRenin-Angiotensin System StudiesRegulation of Appetite and Obesity

Genetic disruption of γ-melanocyte–stimulating hormone signaling leads to salt-sensitive hypertension in the mouse

Open access
Ni, Xi-Ping, Pearce, David, Butler, Andrew A., Cone, Roger D., Humphreys, Michael H.·2003·Journal of Clinical Investigation

Abstract

The γ-melanocyte-stimulating hormone (γ-MSH) is a natriuretic peptide derived from the N-terminal region of proopiomelanocortin (POMC). Evidence suggests that it may be part of the coordinated response to a low-sodium diet (LSD). We tested the effect of the HSD (8% NaCl) compared with LSD (0.07%) on mean arterial pressure (MAP) in mice with targeted disruption of the PC2 gene (PC2(–/–)), necessary for processing of POMC into γ-MSH, or the melanocortin receptor 3 gene (Mc3r(–/–); the receptor for MSH). In wild-type mice, HSD for 1 week did not alter MAP versus LSD mice, but plasma γ-MSH immunoreactivity was more than double the LSD value. In contrast, in PC2(–/–) mice, MAP on the LSD was not greater than in wild-type mice, but plasma γ-MSH was reduced to one-seventh the wild-type value. On the HSD, MAP rose to a markedly hypertensive level while plasma γ-MSH concentration remained severely depressed. Intravenous infusion of γ-MSH (0.2 pmol/min) for 30 min to PC2(–/–) mice after 1 week of HSD lowered MAP from hypertensive levels to normal; infusion of α-MSH at the same rate had no effect. Injection of 60 fmol of γ-MSH into the lateral cerebral ventricle of hypertensive mice also lowered MAP to normal. Administration of a stable analogue of γ-MSH intra-abdominally by microosmotic pump to PC2(–/–) mice prevented the development of hypertension when ingesting the HSD. In mice with targeted disruption of the Mc3r gene, the HSD also led to marked hypertension accompanied by elevated plasma levels of γ-MSH; infusion of exogenous γ-MSH to these mice had no effect on MAP. These results strongly suggest that PC2-dependent processing of POMC into γ-MSH is necessary for the normal response to the HSD. γ-MSH deficiency results in marked salt-sensitive hypertension that is rapidly improved with exogenous γ-MSH through a central site of action. α-MSH infused at the same rate had no effect on MAP, indicating that the hypertension is a specific consequence of impaired POMC processing into γ-MSH. Absence of Mc3r produces γ-MSH resistance and hypertension on the HSD. These findings demonstrate a novel pathway mediating salt-sensitivity of blood pressure.

Integrity signals

Registry

Crossref · 10.1172/jci200316993

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mice with genetic deficiency of MC3R or PC2 increase salt sensitivity of blood pressure.

    “Support for this hypothesis comes from studies showing that mice with genetic deficiency of MC3R or PC2, which reduces formation of γ-MSH, increase salt sensitivity of BP in mice [22].”

    From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [22]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ni, X.-P., Pearce, D., Butler, A. A., Cone, R. D., & Humphreys, M. H.
Affiliations
  • San Francisco General Hospital (US)
  • Oregon Health & Science University (US)
Corresponding author
Humphreys, Michael H.
Venue
Journal of Clinical Investigation
Published
2003-04-15
Volume
111
Issue
8
Pages
1251-1258
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2027637340
Cited by
74
References
51
Citations by year
2026: 1 · 2025: 3 · 2021: 4 · 2020: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 3
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL068871, HL 68871)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P01DK055819, R01DK051730, DK 58812, DK51730, DK 55819, DK-56695, R01DK058812, R01DK056695)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
gamma-MSH, salt-sensitive hypertension, PC2, sodium restriction, high-salt diet, mean arterial pressure, natriuretic peptides, alpha-melanocyte-stimulating hormone, central nervous system, gene disruption, mice
MeSH terms
Animals, Genotype, Hypertension, Mice, Inbred C57BL, Subtilisins, Sodium Chloride, Dietary, Receptors, Corticotropin, gamma-MSH, Receptor, Melanocortin, Type 3, Proprotein Convertase 2, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review